Jpmorgan Chase & CO Simulations Plus, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 147,154 shares of SLP stock, worth $5.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
147,154
Previous 47,365
210.68%
Holding current value
$5.3 Million
Previous $1.52 Million
170.71%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding SLP
# of Institutions
174Shares Held
15.9MCall Options Held
5.4KPut Options Held
1.4K-
Black Rock Inc. New York, NY2.46MShares$88.9 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC2.23MShares$80.3 Million0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$41.3 Million0.0% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX902KShares$32.5 Million1.9% of portfolio
-
State Street Corp Boston, MA640KShares$23.1 Million0.0% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $732M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...